Description
Bdfucil 100mg/224mg Capsule is a prescription medicine which is a combination of two anticancer medicines that is used in the treatment of cancer of the colon and rectum. It prevents the growth and multiplication of cancer cells, thus helps in destroying the tumor.
Bdfucil 100mg/224mg Capsule may be taken with or without food. It should be used in the dose and duration as prescribed by your doctor. It is advised to take this medicine at a fixed time.
This medicine should not be taken more than the recommended dose. If you miss any dose, please consult your doctor. It is advised to complete the treatment without any interruption. This medicine is usually well tolerated by patients.
The common side effects of this medicine include nausea, vomiting, hair loss, low number of blood cells (anemia) and a decrease in white blood cell count. The doctor may ask you to undergo a few blood tests before or during the treatment.
Your doctor may prescribe you to undergo blood tests before or during the treatment. You may be given supplements to overcome the deficiency caused by this medicine. It is advised to add more vegetables and fruits in your diet to overcome any such deficiency.
This medicine is not safe to use in pregnancy. Inform your doctor if you are taking any other medicines or if you are breastfeeding. Inform your doctor if you are suffering from any disease. It is strictly advised not to drive or operate heavy machinery while you are on the treatment.
Bdfucil 100mg/224mg Capsule is a combination of two medicines: Tegafur and Uracil which treat cancer. They work by interfering with the growth of DNA and RNA of cancer cells by substituting their building blocks. This prevents the cancer cells from growing and multiplying.
We have strong global networks in Africa, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Middle East and South East Countries.
Explore more products anti cancer
Reviews
There are no reviews yet.